Robbins Geller provides comprehensive securities fraud monitoring solutions for its clients who invest globally. By providing clients with the ability to identify and assess their losses associated with securities fraud, clients are given the information necessary to maximize their potential recoveries worldwide.
Robbins Geller was recently selected to advise the largest local authority pension fund in the United Kingdom, the £16 billion Greater Manchester Pension Fund, on corporate governance and shareholder actions. “We are pleased to have access to the expert advice of Robbins Geller. They have a long-proven track record of vigorously and effectively protecting shareholder rights and we value their input,” said Councillor Kieran Quinn, Executive Leader of Tameside Metropolitan Borough Council, Chair of Greater Manchester Pension Fund and Chair of Local Authority Pension Fund Forum. The fund won 2014 Large Scheme of the Year and also Best Member Communications Awards from Professional Pensions magazine.
Participants in Robbins Geller’s Portfolio Monitoring Program® receive a monthly Portfolio Monitoring Report and monthly Settlement Report. The Portfolio Monitoring Report provides information on U.S. securities class actions. The Settlement Report provides detailed information on U.S. and international settlements that have approaching claim deadlines.
Robbins Geller’s Portfolio Monitoring Program® is used all over the world by pension fund trustees, fund managers and institutional investors. The Firm currently monitors hundreds of institutional investor funds with more than $2 trillion in total assets.
Read More Firm News
- The National Law Journal Recognizes Robbins Geller as 2021 Elite Trial Lawyers Finalist in Securities Litigation, Class Action, and Privacy/Data Breach Practice AreasMay 12, 2021
- Robbins Geller Partners Aelish Baig and Jessica Shinnefield Recognized as “Born Leaders” and Plaintiffs’ Lawyers Trailblazers by The National Law JournalMay 4, 2021
- Robbins Geller Secures Appellate Win After Supreme Court of New York Appellate Division Affirms Denial of Motion to Dismiss in Securities Class Action Against Alnylam Pharmaceuticals, Inc.April 30, 2021
- April 29, 2021
- April 22, 2021